Category Archives: Infringement

Sharp and Vizio not shown to infringe Wi-Lan’s flicker effect patents, FC panel affirmed

Wi-Lan Inc. v. Sharp Electronics Corporation, Vizio, Inc. Docket No. 2020-1041, -1043 (http://www.cafc.uscourts.gov/sites/default/files/opinions-orders/20-1041.OPINION.4-6-2021_1759180.pdf) MOORE, REYNA, HUGHES April 6, 2021 Brief Summary:  DC grant of SJ of non-infringement and claim construction findings affirmed. Summary:  Wi-Lan appealed DC finding that neither Sharp … Continue reading

Posted in Claim Construction, Expert Testimony, Infringement | Leave a comment

DC grant of SJ to SIMO reversed without remand due to improper construction of preamble

SIMO Holdings Inc. v. Hong Kong uCloudlink et al. Docket No. 2019-2411 (http://www.cafc.uscourts.gov/sites/default/files/opinions-orders/19-2411.OPINION.1-5-2021_1711937.pdf) O’MALLEY, WALLACH, TARANTO January 5, 2021 Brief Summary:  DC claim construction and grant of SJ to SIMO reversed due to improper interpretation of preamble language. Summary:  uCloud … Continue reading

Posted in Claim Construction, Infringement, Preamble | Leave a comment

Infringement by Hospira’s ANDA of Par’s epinephrin injection-related claims affirmed

Par Pharmaceutical, Inc. et al. v. Hospira, Inc. Docket No. 2020-1273 (http://www.cafc.uscourts.gov/sites/default/files/opinions-orders/20-1273.OPINION.11-23-2020_1689851.pdf) DYK, TARANTO, STOLL November 23, 2020 Non-precedential Brief Summary:  DC finding that Hospira’s ANDA infringed Par’s claims affirmed (e.g., “[w]hat a generic asks for an receives approval to … Continue reading

Posted in Claim Construction, Generics / ANDA, Infringement | Leave a comment

DC ineligibility decision erroneous as claims not “solely directed to the printed matter”

C. R. Bard, et al. v. AngioDynamics, Inc. Docket No. 2019-1756, -1934 (http://www.cafc.uscourts.gov/sites/default/files/opinions-orders/19-1756.OPINION.11-10-2020_1683097.pdf) REYNA, SCHALL, STOLL November 10, 2020 Brief Summary:  DC erroneously granted JMOL based on expert mistake and conclusion that printed matter made claims patent ineligible under section … Continue reading

Posted in Inducement to Infringe, Infringement, Patent Eligibility (101), Patentability | Leave a comment

DC infringement decision affirmed for one patent, preambles found limiting as to two others, money damages affirmed, injunction for two of four accused products vacated

Bio-Rad Labs., Inc., The Univ. of Chicago v. 10X Genomics Inc. Docket No. 2019-2255, -2285 NEWMAN, O’MALLEY, TARANTO August 3, 2020 Brief Summary: DC decision of infringement of ‘083 patent under DOE affirmed; preamble found to limit ‘407 and ‘193 … Continue reading

Posted in Claim Vitiation, Damages, Doctrine of equivalents, Infringement, Willfullness | Leave a comment

DC non-infringement decision affirmed due to disclosure-dedication doctrine

Eagle Pharmaceuticals Inc. v. Slayback Pharma LLC Docket No. 2019-1924 O’MALLEY, REYNA, CHEN May 8, 2020 Brief Summary: DC finding of no infringement under DOE based on disclosure-dedication doctrine affirmed. Summary: Eagle appealed DC judgment of non-infringement of US Pat. … Continue reading

Posted in Claim Construction, Doctrine of equivalents, Infringement | Leave a comment

Injunction, damages, infringement and invalidity decisions regarding Illumina’s fetal testing patents affirmed

Verinata Health, Inc., Illumina, Inc. v. Ariosa Diagnostics, Inc., Roche Mol. Sys., Inc. Docket No. 22018-2198, -2303, -2305, -2306, -2317 REYNA, WALLACH, HUGHES April 24, 2020 (Non-precedential) Brief Summary: DC denial of injunction and damages, as well as its refusal … Continue reading

Posted in Anticipation (35 USC 102), Doctrine of equivalents, Enablement, Infringement, Software | Leave a comment

Rejected claim construction proposal during IPR was not prosecution history estoppel, FC affirms infringement under DOE; second infringement decision reversed

Galderma Labs., Nestle Skin Health S.A. et al. v. Amneal Pharm. LLC et al. Docket No. 2019-1021 LOURIE, MOORE, STOLL March 25, 2020 Non-Precedential Brief Summary: DC finding of infringement of certain claims affirmed as statements made in related IPR … Continue reading

Posted in Claim Construction, Doctrine of equivalents, Infringement, Inter Parties Review (IPR), IPR, Prosecution History Estoppel, Uncategorized | Leave a comment

DC obviousness and infringement decisions regarding coffee filter claims affirmed

Eko Brands, LLC v. Adrian Rivera Maynez Ent., Inc. et al. (“ARM”) Docket No. 2018-2215, -2254 DYK, REYNA, HUGHES January 13, 2020 Brief Summary: DC decisions that ARM’s claims are invalid for obviousness and not infringed, and that ARM willfully … Continue reading

Posted in Claim Construction, Infringement, Obviousness, Uncategorized, Willfullness | Leave a comment

Fed. Cir. reverses DC and finds Amneal’s Sensipar®-related product infringes Amgen ‘405 patent

Amgen Inc. v. Amneal Pharm., Pirimal, et al., Zydus Pharm., Cadila et al. Docket Nos. 2018-2414, 2019-1086 NEWMAN, LOURIE, TARANTO January 7, 2020 Brief Summary: DC claim construction reversed (“composition comprising” not closed to other components); no infringement by Amneal … Continue reading

Posted in Claim Construction, Generics / ANDA, Infringement | Leave a comment